Takeda Ruling Could Limit FCA Enforcement, 1st Circ. Hears

Law360, Los Angeles (August 2, 2013, 8:26 PM EDT) -- The federal government on Thursday asked the First Circuit to overturn a ruling that Takeda Pharmaceutical Co. Ltd. wasn't liable for failure to tell the U.S. Food and Drug Administration about health complications tied to its drugs, arguing the decision would limit the government's False Claims Act enforcement.

A former Takeda contractor claims in two qui tam suits that the company cost the government billions in overpayments by not reporting the alleged health risks. But a Massachusetts federal judge ruled last year that the potential of the...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.